More than 30 Babies Mistakenly Vaccinated with Pfizer or GSK’s RSV Shots

At least 34 babies were mistakenly given the respiratory syncytial virus (RSV) vaccine and one of those babies was hospitalized according to a study published today in Pediatrics.

Researchers from the Centers for Disease Control and Prevention (CDC) analyzed data from the Vaccine Adverse Event Reporting System (VAERS) for the RSV vaccines, which are not approved for children.

The researchers found 27 reports of the Pfizer RSV vaccine (Abrysvo) and seven reports of the GSK RSV vaccine (Arexvy) mistakenly administered to children under 2 between Aug. 21, 2023, and March 18, 2024.

“While rare, vaccine administration errors are known to occur and may increase after a new vaccine or product is introduced,” Dr. Pedro Moro, lead author of the study, told MedPage Today.

Both vaccines were first approved in May 2023 for people ages 60 and older. Pfizer’s Abrysvo was approved in August 2023 for pregnant mothers during part of their third trimester, targeting RSV prevention in babies.

Keep reading

Pfizer To Bypass Doctors, Pharmacies By Selling Drugs Online Directly To Consumers: Report

Pfizer is forging ahead with plans to introduce a direct-to-consumer platform for online sales of some of its medications, including Paxlovid and a migraine nasal spray.

The Defender reports that this initiative marks the latest maneuver by major pharmaceutical companies to circumvent conventional routes of distribution through primary care physicians and brick-and-mortar pharmacies. 

Pfizer is set to roll out its platform before the year’s end. 

Its website will enable patients in the U.S. to consult independent telehealth professionals for prescriptions, with an online pharmacy partner handling the fulfillment and shipping of orders, per the Financial Times.

Keep reading

Toddler Dies in Pfizer Gene Therapy Trial

Yesterday I republished a video and article entitled, “What Happened to Their Babies,” describing the lack of ethics and grossly inhumane experimentation that Pfizer conducted on babies and toddlers with their COVID-19 mRNA gene-editing injections.

Just a few hours ago, multiple industry outlets began breaking this official statement from Pfizer that a toddler died of a cardiac arrest in an investigational trial of boys, aged 2 to 4 year olds, to treat a rare form of muscular dystrophy with a recombinant adenovirus gene editing technology.

Keep reading

Pfizer agrees to settle 10,000 lawsuits accusing pharma giant of hiding cancer risks of heartburn drug Zantac

Pfizer has agreed to settle more than 10,000 lawsuits alleging it it of hiding the cancer risks of its heartburn drug Zantac.

The financial details have not been revealed but pharma rival Sanofi agreed to pay more than $100million to resolve 4,000 Zantac-cancer claims last nonth.

The over-the-counter pill was pulled in the US in 2020 after animal studies found a key ingredient released ‘probable human carcinogens’.

Pfizer was the primary manufacturer of Zantac from 1998 to 2006, when several suits claim it should have known that the drug was contaminated with NDMA.

Plaintiffs claimed the drug was contaminated with the impurity through improper manufacturing practices, and that Pfizer withheld this information from consumers.

NDMA is a chemical byproduct of many industrial manufacturing processes, including the production of rocket fuel.

Keep reading

AstraZeneca withdraws Covid vaccine worldwide

AstraZeneca pharmaceutical company has announced the withdrawal of its Covid-19 vaccine from global markets, claiming the drug has been sidelined by alternatives.

The development comes after the drug manufacturer recently admitted that the vaccine can cause potentially fatal blood clots in rare cases.

In a statement on Wednesday, cited by multiple media outlets, a spokesperson for AstraZeneca said multiple variants of the vaccine had been developed since the start of the pandemic, leading to a decline in demand for Vaxzevria, which is no longer being manufactured or developed. A spokesman also cited independent estimates claiming that “over 6.5 million lives were saved in the first year of use alone and over 3 billion doses were supplied globally.”

The AstraZeneca vaccine was rolled out in early 2021, shortly after the Covid-19 outbreak was declared a pandemic by the World Health Organization. AstraZeneca voluntarily withdrew its market authorization for the vaccine in the EU last March, with the European Medicines Agency confirm.

Shortly after the rollout, AstraZeneca found itself at the center of controversy after numerous Western countries suspended the use of its vaccine over fears that it may have caused some patients to develop blood clots. However, EU health officials at the time insisted that the benefits of the inoculation still outweighed the risks.

Keep reading

Historic Drug Shortage Exacerbated by EPA Overreach

Concerning new reports reveal that the drug shortage in the U.S. has reached its highest level since the American Society of Health-System Pharmacists began tracking data. In total, 323 medicines are now in short supply.

However, the problem is about to get worse because of government regulations on an entirely different issue. Counterintuitive measures from the Environmental Protection Agency (EPA) are set to effectively ban the domestic production of chemicals that are used in the process of manufacturing vital prescription drugs and vaccines.

Shortly after Congress amended the Toxic Substances Control Act (TSCA) in 2016, the EPA began the rulemaking process on 10 chemicals currently in use in the United States using a broad and overreaching definition of “unreasonable risk.” Now, the EPA is expected to release a final rule on methylene chloride under TSCA.

Methylene chloride has several applications, including in the process of manufacturing hundreds of medicines and vaccines like those that treat Hepatitis B and HIV infectionsmental illnesses and epilepsyheart failure and high blood pressure, and high cholesterol.

If this rule goes into effect, it will exacerbate the drug shortage by bringing domestic manufacturing to a halt while making our supply chains more reliant on foreign nations like China for pharmaceuticals. This runs in direct contradiction to the Biden administration’s “Investing in America” agenda, which aims to onshore supply chains critical to our economy and security.

For example, methylene chloride is used to make hollow fiber cartridges which are used in the manufacture of monoclonal antibodies and vaccines, including the COVID-19, HPV, Hepatitis B, and flu vaccines, as well as therapies for arthritis, migraines, osteoporosis, and autoimmune diseases. In a letter to the EPA, the company that produces these cartridges wrote their product is used in at least 190 human therapeutics and vaccines. Their supply is so essential that the U.S. Department of Health and Human Services and the Defense Department awarded the company funding to expand its manufacturing capacity here in the U.S.

Keep reading

Doctors do more harm than good

We now spend more on health care than ever before, and the medical profession is apparently more scientific and better equipped than ever before, so there is a savage irony in the fact that we have now reached the point where, on balance, well-meaning doctors in general practice and highly trained, well-equipped specialists working in hospitals do more harm than good. The epidemic of iatrogenic disease which has always scarred medical practice has been steadily getting worse and today most of us would, most of the time, be better off without a medical profession.

Most developed countries now spend around 8% of their gross national products on health care (the Americans spend considerably more – around 12-14%) but through a mixture of ignorance, incompetence, prejudice, dishonesty, laziness, paternalism and misplaced trust doctors are killing more people than they are saving and they are causing more illness and more discomfort than they are alleviating.

Most developed countries now spend around 1% of their annual income on prescription drugs and doctors have more knowledge and greater access to powerful treatments than ever before, but there has probably never been another time in history when doctors have done more harm than they do today.

It is true, of course, that doctors save thousands of lives by, for example, prescribing life-saving drugs or by performing essential life-saving surgery on accident victims.

But when the medical profession, together with the pharmaceutical industry, claims that it is the advances in medicine which are responsible for the fact that life expectancy figures have risen in the last one hundred years or so they are wrong. It is, for example, commonly claimed that modern scientific medicine has led to improvements in life expectancy in most developed countries from around 55 at the start of the century to over 70 today.

The evidence, however, does not support this claim.

Any (small) improvement in life expectancy which has occurred in the last hundred years is not related to developments in the medical profession or to the growth of the international drug industry. However, the increase in iatrogenesis is related to both these factors.

Whichever facts you look they at seem to support my contention that although doctors may do a limited amount of good, they do a great deal more harm.

If doctors really did help people stay alive then you might expect to find that the countries which had the most doctors would have the best life expectation figures. But that isn’t the case at all.

Keep reading

Pharma companies ‘bribed NHS doctors to use infected blood products’ that gave patients HIV and hepatitis C

Pharmaceutical companies have been accused of bribing NHS doctors to use infected blood products that gave people HIV and hepatitis C in the 1970s and 1980s.

NHS hospitals were offered money to buy blood products from US pharma giants, who were known to have paid high-risk donors for their plasma, the Telegraph has reported. 

Around 1,250 people with haemophilia were infected with HIV and another 5,000 contracted hepititis C after they were given the blood-clotting drug Factor VIII. 

Now a letter dated from January 1981 reveals that St Thomas’ Hospital in London was offered £8,500 (around £41,000 today) in rebates for buying Factor VIII made in the US. 

The letter – which has been published in the book The Poison Line by Cara McGoogan – shows that doctors were offered to purchase four million units of Factor VIII produced by Bayer and Baxter Healthcare in return for monetey incentives.

Jason Evans, director of the campaign group Factor 8, told the Telegraph: ‘Doctors were literally offered cash to use dangerous products.

‘In my opinion, on behalf of the pharmaceutical companies, this basically amounts to bribery.’

The haemophilia centre at St Thomas’ – run by Dr Geoffrey Savidge – was known to have some of the highest rates of Factor VIII use per patient in the UK, according to Professor Edward Tuddenham.

The leading haematologist and emeritus professor at the Royal Free in London said: ‘Dr Savidge was known for years for using American concentrate. He had very well-equipped laboratories.’

Although Dr Savidge died in 2011, an earlier inquiry in 2007, found that ‘he used almost exclusively commercial products but he shouldn’t have done.’

Around 3,000 people died due to the infected blood scandal in the 1970s and 1980s which has been dubbed the biggest treatment disaster in NHS history. 

Keep reading

Personalised medicine will make drug experimentation on populations the norm

In June 2023, the UK’s Medicines and Healthcare products Regulatory Agency (“MHRA”) announced it will be the first drug safety regulator in the world to pilot its own genetic “biobank,” to better understand how a patient’s genetic makeup can impact the safety of their medicines.

“The Yellow Card biobank, which will contain genetic data and patient samples … forms part of a long-term vision for more personalised medicine approaches … [to] enable doctors to target prescriptions using rapid screening tests, so patients … receive the safest medication for them, based on their genetic makeup,” a press release said.

In February 2024, as a personalised medicine project, the MHRA began recruiting patients who have experienced excessive bleeding after taking blood thinners to establish whether they have any special genetic traits which predispose them to excessive bleeding.

It may sound exciting however, personalised genetic medicine is a step towards an era where drug use and experimentation on populations become the norm.

As Dr. Guy Hatchard notes, whilst most pharmaceutical drugs entail adverse reactions and unanticipated side effects, drugs that are tailored to genetic characteristics may potentially have even more serious consequences and long-term adverse outcomes. This is because genetic systems are involved in all the functions of the physiology, its organs, bio-molecular messaging and overall immunity.

Keep reading

Prescription Drugs Are the Leading Cause of Death

Overtreatment with drugs kills many people, and the death rate is increasing. It is therefore strange that we have allowed this long-lasting drug pandemic to continue, and even more so because most of the drug deaths are easily preventable. 

In 2013, I estimated that our prescription drugs are the third leading cause of death after heart disease and cancer,1 and in 2015, that psychiatric drugs alone are also the third leading cause of death.2 However, in the US, it is commonly stated that our drugs are “only” the fourth leading cause of death.3,4 This estimate was derived from a 1998 meta-analysis of 39 US studies where monitors recorded all adverse drug reactions that occurred while the patients were in hospital, or which were the reason for hospital admission.5

This methodology clearly underestimates drug deaths. Most people who are killed by their drugs die outside hospitals, and the time people spent in hospitals was only 11 days on average in the meta-analysis.5 Moreover, the meta-analysis only included patients who died from drugs that were properly prescribed, not those who died as a result of errors in drug administration, noncompliance, overdose, or drug abuse, and not deaths where the adverse drug reaction was only possible.5 

Many people die because of errors, e.g. simultaneous use of contraindicated drugs, and many possible drug deaths are real. Moreover, most of the included studies are very old, the median publication year being 1973, and drug deaths have increased dramatically over the last 50 years. As an example, 37,309 drug deaths were reported to the FDA in 2006 and 123,927 ten years later, which is 3.3 times as many.6 

In hospital records and coroners’ reports, deaths linked to prescription drugs are often considered to be from natural or unknown causes. This misconception is particularly common for deaths caused by psychiatric drugs.2,7 Even when young patients with schizophrenia suddenly drop dead, it is called a natural death. But it is not natural to die young and it is well known that neuroleptics can cause lethal heart arrhythmias. 

Many people die from the drugs they take without raising any suspicion that it could be an adverse drug effect. Depression drugs kill many people, mainly among the elderly, because they can cause orthostatic hypotension, sedation, confusion, and dizziness. The drugs double the risk of falls and hip fractures in a dose-dependent manner,8,9 and within one year after a hip fracture, about one-fifth of the patients will have died. As elderly people often fall anyway, it is not possible to know if such deaths are drug deaths.

Another example of unrecognised drug deaths is provided by non-steroidal anti-inflammatory drugs (NSAIDs). They have killed hundreds of thousands of people,1 mainly through heart attacks and bleeding stomach ulcers, but these deaths are unlikely to be coded as adverse drug reactions, as such deaths also occur in patients who do not take the drugs. 

The 1998 US meta-analysis estimated that 106,000 patients die every year in hospital because of adverse drug effects (a 0.32% death rate).5 A carefully done Norwegian study examined 732 deaths that occurred in a two-year period ending in 1995 at a department of internal medicine, and it found that there were 9.5 drug deaths per 1,000 patients (a 1% death rate).10 This is a much more reliable estimate, as drug deaths have increased markedly. If we apply this estimate to the US, we get 315,000 annual drug deaths in hospitals. A review of four newer studies, from 2008 to 2011, estimated that there were over 400,000 drug deaths in US hospitals.11

Drug usage is now so common that newborns in 2019 could be expected to take prescription drugs for roughly half their lives in the US.12 Moreover, polypharmacy has been increasing.12 

Keep reading